Stratview Research announces the launch of a new research report on the Fiducial Markers Market by Product (Gold, Gold Combination, Polymer, Other Metals, Liquid), by Modality (CT/CBCT, MRI, Ultrasound, X-Ray), by Application (Breast Cancer, Lung Cancer, Prostate Cancer, Head, and Neck Cancer, Others), by End-Use (Hospitals, Radiotherapy Center, Academic, and Research Center), and Region (North America, Europe, Asia-Pacific, and Rest of the World).

Highlights from the Report

The fiducial markers market was estimated at USD 113.07 million in 2021 and is likely to grow at a CAGR of 4.34% during 2022-2028 to reach USD 152.77 million in 2028.

What is a fiducial marker?

A fiducial marker is a medical device that is mainly placed on the object or body so that it can mark the area that needs to get surgery. These markers are very tiny equipment of the size of rice grains, which can help to target cancerous tumours or tissues without affecting the healthy ones. This device enables to mark off the exact position of the tumour and can help the doctor to provide maximum radiation dose to the particular area consisting of the tumour without harming the surrounding tissues.

Report Features

This report provides critical insights into the market dynamics and enables strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis.
• Market environment analysis: Growth drivers and constraints
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities
• Key success factors

This report studies the Fiducial Markers Market and has segmented the market in few ways, keeping in mind the interest of all the stakeholders across the value chain. Following are the ways in which the market is segmented.

By Product Trends

By product, the fiducial markers market has been categorized into gold, gold combination, polymer, other metals, and liquid.

Under these, the gold segment witnessed the highest market share in 2021 and is likely to register a significant CAGR during the review period.

This is mainly attributed to the accurate visibility and excellent stability of these products across various imaging modalities. Also, gold fiducial markers come in combination with various metals, such as platinum, titanium, and nickel, for better efficiency.

Regional Trends

By region, the North American market garnered the largest market share in 2021 and is projected to grow at a substantial CAGR during the assessment period.

This is mainly ascribed to streamlined reimbursement policies, the strong presence of key market players, and public health programs in the region. Growing healthcare expenditure and rising adoption of advanced radiotherapy procedures & imaging modalities further boost regional growth.

Following are the key players in the Fiducial Markers Market:

• CIVCO Radiotherapy (The U.S),
• IZI Medical Products (The U.S),
• Naslund Medical AB (Sweden),
• Medtronic, Inc. (Ireland),
• QlRad Inc. (Netherlands),
• QFix (The U.S),
• Boston Scientific Corporation (The U.S),
• Nanovi A/S (Denmark),
• Eckert & Ziegler (Belgium), and
• IBA Dosimetry GmbH (Germany).

About Stratview Research-

Stratview Research is a global market intelligence firm having a strong experienced team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. The services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.

Connect with the team –

Call @:  +1-313-307-4176

Mail @:  [email protected]